Pathogenic Escherichia coli

Nature Reviews Microbiology

Volumn 2, Issue 2, 2004, Pages 123-140

  Kaper, James B ^a,b   Nataro, James P ^a,b   Mobley, Harry L T ^b  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI PROTEIN; INTIMIN; MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN; TRANSFER RNA; VIRULENCE FACTOR; SHIGA TOXIN;

BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; CROHN DISEASE; DIARRHEA; DNA HYBRIDIZATION; ENTEROPATHY; EPITHELIUM CELL; ESCHERICHIA COLI; FIMBRIA; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC CODE; GRAM NEGATIVE SEPSIS; HISTOPATHOLOGY; HUMAN; INTESTINE FLORA; NONHUMAN; PATHOGENESIS; PATHOTYPE; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; SIGNAL TRANSDUCTION; VERNER MORRISON SYNDROME; ANIMAL; GENETICS; PATHOGENICITY; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA; NEGIBACTERIA;

ANIMALS; BACTERIAL ADHESION; DIARRHEA; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MENINGITIS, BACTERIAL; SHIGA TOXINS; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 1842508193     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro818     Document Type: Review

References (157)

1. Sweeney, N. J. et al. The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine. Infect. Immun. 64, 3497-3503 (1996).
2. Nataro, J. P. & Kaper, J. B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11, 142-201 (1998).
3. Russo, T. A. & Johnson, J. R. Proposal for a new inclusive designation for extraintestinal pathogenic isolated of Escherichia coli: ExPEC. J. Infect. Dis. 181, 1753-1754 (2000).
4. Whittam, T. S. in Escherichia coli and Salmonella (eds Neidhardt, F. C. et al.) 2708-2720 (ASM Press, Washington DC, USA, 1996).
5. Cassell, F. J. & Wolf, M. K. Colonization factors of diarrheagenic E. coli and their intestinal receptors. J. Ind. Microbiol. 15, 214-226 (1995).
6. Keller, R. et al. Afa, a diffuse adherence fibrillar adhesin associated with enteropathogenic Escherichia coli. Infect. Immun. 70, 2681-2689 (2002).
7. Tieng, V. et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc. Natl Acad. Sci. USA 99, 2977-2982 (2002).
8. Goldberg, M. B. & Theriot, J. A. Shigella flexneri surface protein IcsA is sufficient to direct actin-based motility. Proc. Natl Acad. Sci. USA 92, 6572-6576 (1995).
9. Tapping, R. I., Akashi, S., Miyake, K., Godowski, P. J. & Tobias, P. S. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J. Immunol. 165, 5780-5787 (2000).
10. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103 (2001).
11. Sears, C. L. & Kaper, J. B. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol. Rev. 60, 167-215 (1996).
12. Melton-Celsa, A. R. & O'Brien, A. D. in Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains (eds Kaper, J. B. & O'Brien, A. D.) 121-128 (ASM Press, Washington DC, USA, 1998 ).
13. De Rycke, J. & Oswald, E. Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation? FEMS Microbiol Lett. 203, 141-148 (2001).
14. 2/M transition. Mol. Microbiol 50 1553-1567 (2003).
15. Lerm, M. et al. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect. Immun. 67, 496-503 (1999).
16. Kenny, B. et al. Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol. Microbiol. 44, 1095-1107 (2002).
17. Tauschek, M., Gorrell, R. J., Strugnell, R. A. & Robins-Browne, R. M. Identification of a protein sacretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc. Natl Acad. Sci. USA 99, 7066-7071 (2002).
18. Henderson, I. R., Navarro-Garcia, F. & Nataro, J. P. The great escape: structure and function of the autotransporter proteins. Trends Microbiol. 6, 370-378 (1998).
19. Hueck, C. J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62 379-433 (1998).
20. Balakrishnan, L., Hughes, C. & Koronakis, V. Substrate-triggered recruitment of the TolC channel-tunnel during type I export of hemolysin by Escherichia coli. J. Mol. Biol. 313, 501-510 (2001).
21. McDaniel, T. K., Jarvis, K. G., Donnenberg, M. S. & Kaper, J. B. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl Acad. Sci. USA 92, 1664-1668 (1995).
22. Jerse, A. E., Yu, J., Tall, B. D. & Kaper, J. B. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl Acad. Sci. USA 87, 7839-7843 (1990).
23. Higgins, L. M. et al. Role of bacterial intimin in colonic hyperplasia and inflammation. Science 285, 588-591 (1999).
24. Kenny, B. et al. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91, 511-520 (1997).
25. Muza-Moons, M. M., Koutsouris, A. & Hecht, G. Disruption of cell polarity by enteropathogenic Escherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences. Infect. Immun. 71, 7069-7078 (2003).
26. Sinclair, J. F. & O'Brien, A. D. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-γ of enterohemorrhagic Escherichia coli O157:H7. J. Biol. Chem. 277, 2876-2885 (2002).
27. Kalman, D. et al. Enteropathogenic E. coli acts through WASP and Arp2/3 complex to form actin pedestals. Nature Cell Biol. 1, 389-391 (1999).
28. Campellone, K. G. & Leong, J. M. Tails of two Tirs: actin pedestal formation by enteropathogenic E. coli and enterohemorrhagic E. coli O157:H7. Curr. Opin. Microbiol. 6, 82-90 (2003).
29. Vallance, B. A. & Finlay, B. B. Exploitation of host cells by enteropathogenic Escherichia coli. Proc. Natl Acad. Sci. USA 97 8799-8806 (2000).
30. Sanger, J. M., Chang, R., Ashton, F., Kaper, J. B. & Sanger J. W. Novel form of actin-based motility transports bacteria on the surface of infected cells. Cell Motil. Cytoskeleton 34, 279-287 (1996).
31. Crane, J. K., McNamara, B. P. & Donnenberg, M. S. Role of EspF in host cell death induced by enteropathogenic Escherichia coli. Cell Microbiol. 3, 197-211 (2001).
32. McNamara, B. P. et al. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J. Clin. Invest. 107, 621-629 (2001).
33. Klapproth, J. M. et al. A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect. Immun. 68, 2148-2155 (2000).
34. Nicholls, L., Grant, T. H. & Robins-Browne, R. M. Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. Mol. Microbiol. 35, 275-288 (2000).
35. Tobe, T. et al. Complete DNA sequence and structural analysis of the enteropathogenic Escherichia coli adherence factor plasmid. Infect. Immun. 67, 5455-5462 (1999).
36. Girón, J. A. Ho, A. S. Y. & Schoolnik, G. K. An inducible bundle-forming pilus of enteropathogenic Escherichia coli. Science 254, 710-713 (1991).
37. Trabulsi, L. R., Keller, R. & Tardelli Gomes, T. A. Typical and atypical enteropathogenic Escherichia coli. Emerg. Infect. Dis. 8, 508-513 (2002).
38. Hecht, G. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VII. Enteropathogenic Escherichia coli physiological alterations from an extracellular position. Am. J. Physiol Gastrointest. Liver Physiol. 281, G1-G7 (2001).
39. Frankel, G. et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30, 911-921 (1998).
40. Kenny, B. Mechanism of action of EPEC type III effector molecules, Int. J. Med. Microbiol. 291, 469-477 (2002).
41. - secretion from intestinal epithelia by upregulating galanin-1 receptor expression. J. Clin. Invest. 104, 253-262 (1999).
42. Varma, J. K. et al. An outbreak of Escherichia coli O157 infection following exposure to a contaminated building. JAMA 290, 2709-2712 (2003).
43. Andreoli, S. P., Trachtman, H., Acheson, D. W., Siegler, R. L. & Obrig, T. G. Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr. Nephrol. 17, 293-298 (2002).
44. Jones, N. L. et al. Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am. J. Physiol. Gastrointest. Liver Physiol. 278, G811-G819 (2000).
45. Reid, S. D., Herbelin, C. J., Bumbaugh, A. C., Selander, R. K. & Whittam, T. S. Parallel evolution of virulence in pathogenic Escherichia coli. Nature 406, 64-67 (2000).
46. Tatsuno, I. et al. toxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype. Infect. Immun. 69, 6660-6669 (2001).
47. Burland, V. et al. The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7. Nucleic Acids Res. 26, 4196-4204 (1998).
48. Lathem, W. W. et al. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol. Microbiol. 45, 277-288 (2002).
49. Perna, N. T. et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409, 529-533 (2001).
50. Heimer, S. R. et al. Urease of enterohemorrhagic Escherichia coli: evidence for regulation by fur and a trans-acting factor. Infect. Immun. 70, 1027-1031 (2002).
51. Wolf, M. K. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin. Microbiol. Rev. 10, 569-584 (1997).
52. Spangler, B. D. Structure and functicn of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56, 622-647 (1992).
53. Pizza, M. et al. Mucosal vaccines: non-toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19, 2534-2541 (2001).
54. Currie, M. G. et al. Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc. Natl Acad. Sci. USA 89 947-951 (1992).
55. Dubreuil, J. D. Escherichia coli STb enterotoxin. Microbiology 143, 1783-1795 (1997).
56. Pitari, G. M. et al. Bacterial enterotoxins are associated with resistance to colon cancer. Proc. Natl Acad. Sci. USA 100, 2695-2699 (2003).
57. Nataro, J. P., Steiner, T. S. & Guerrant, R. L. Enteroaggregative Escherichia coli. Emerg. Infect. Dis. 4, 251-261 (1998).
58. Hicks, S., Candy, D. C. A. & Philips, A. D. Adhesion of enteroaggregative Escherichia coli to pediatric intestinal mucosa in vitro. Infect. Immun. 64, 4751-4760 (1996).
59. Vial, P. A. et al. Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J. Infect. Dis. 158, 70-79 (1988).
60. Benjamin, P., Federman, M. & Wanke, C. A. Characterization of an invasive phenotype associated with enteroaggregative Escherichia coli. Infect. Immun. 63, 3417-3421 (1995).
61. Abe, C. M., Knutton, S., Pedroso, M. Z., Freymuller, E. & Gomes, T. A. An enteroaggregative Escherichia coli strain of serotype O111:H12 damages and invades cultured T84 cells and human colonic mucosa. FEMS Microbiol. Lett. 203, 199-205 (2001).
62. Czeczulin, J. R. et al. Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect. Immun. 65, 4135-4145 (1997).
63. Nataro, J. P. et al. Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect. Immun. 60, 2297-2304 (1992).
64. Nataro, J. P., Yikang, D., Yingkang, D. & Walker, K. AggR, a transcriptional activator of aggregative adherence fimbria I expression in enteroaggregative Escherichia coli. J. Bacteriol. 176, 4691-4699 (1994).
65. Sheikh, J. et al. A novel dispersin protein in enteroaggregative Escherichia coli. J. Clin. Invest. 110, 1329-1337 (2002).
66. Steiner, T S., Nataro, J. P., Poteet-Smith, C. E., Smith, J. A. & Guerrant, R. L. Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J. Clin. Invest 105, 1769-1777 (2000).
67. Henderson, I. R., Czeczulin, J., Eslava, C., Noriega, F. & Nataro, J. P. Characterization of Pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect. Immun. 67, 5587-5596 (1999).
68. Noriega, F. R., Liao, F. M. Formal, S. B., Fasano, A. & Levine, M. M. Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. J. Infect Dis. 172, 1408-1410 (1995).
69. Savarino, S. J. et al. Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc. Natl Acad. Sci. USA 90, 3093-3097 (1993).
70. Menard, L. P. & Dubreuil, J. D. Enteroaggregative Escherichia coli heat-stable enterotoxin 1 (EAST1): a new toxin with an ad twist. Crit. Rev. Microbiol. 28, 43-60 (2002).
71. Navarro-Garcia, F. et al. In vitro effects of a high-molecular weight heat-labile enterotoxin from enteroaggregative Escherichia coli. Infect. Immun. 66, 3149-3154 (1998).
72. Jiang, Z. D., Greenberg, D., Nataro, J. P., Steffen, R. & DuPont, H. L. Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers. J. Clin. Microbiol. 40, 4185-4190 (2002).
73. Wei, J. et al. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect. Immun. 71, 2775-2786 (2003).
74. Pupo, G. M., Lan, R. & Reeves, P. R. Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics Proc. Natl Acad. Sci. USA 97, 10567-10572 (2000).
75. Sansonetti, P. Host-pathogen interactions: the seduction of molecular cross talk. Gut 50, Suppl. 3 S2-S8 (2002).
76. Zychlinsky, A., Prevost, M. C. & Sansonetti, P. J. Shigella flexneri induces apoptosis in infected macrophages. Nature 358, 167-169 (1992).
77. Buchrieser, C. et al. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol. Microbiol. 38, 760-771 (2000).
78. Egile, C. et al. Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility. J. Cell Biol. 146, 1319-1332 (1999).
79. Sansonetti, P. J. et al. Caspase-1 activation of IL-1β and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity. 12, 581-590 (2000).
80. Tran Van Nhieu, G., Bourdet-Sicard, R., Dumenil, G., Blocker, A. & Sansonetti, P. J. Bacterial signals and cell responses during Shigella entry into epithelial cells. Cell. Microbiol. 2, 187-193 (2000).
81. 5P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 21, 5069-5078 (2002).
82. Scaletsky, I. C. et al. Diffusely adherent Escherichia coli as a cause of acute diarrhea in young children in northeast Brazil: a case-control study. J. Clin. Microbiol. 40 645-648 (2002).
83. Bilge, S. S., Clausen, C. R., Lau, W. & Moseley, S. L. Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEP-2 cells. J. Bacteriol. 171, 4281-4289 (1989).
84. Hasan, R. J. et al. Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation. Infect. Immun. 70, 4485-4493 (2002).
85. Bernet-Camard, M. F., Coconnier, M. H., Hudault, S. & Servin, A. L. Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells. Infect. Immun. 64, 1918-1928 (1996).
86. Peiffer, I., Servin, A. L. & Bernet-Camard, M. F. Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells. Infect. Immun. 66, 4036-4042 (1998).
87. Peiffer, I., Bernet-Camard, M. F., Rousset, M. & Servin, A. L. Impairments in enzyme activity and biosynthesis of brush border-associated hydrolases in human intestinal Caco2/TC7 cells infected by members of the Afa/Dr family of diffusely adhering Escherichia coli. Cell. Microbiol. 3, 341-357 (2001).
88. Philips, I. et al. Epidemic multiresistant Escherichia coli infection in West Lambeth Health District. Lancet 1, 1038-1041 (1988).
89. Manges, A. R. et al. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 345, 1007-1013 (2001).
90. Nowicki, B., Svanborg-Eden, C., Hull, R. & Hull, S. Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect. Immun. 57, 446-451 (1989).
91. Johnson, J. R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4, 80-128 (1991).
92. Johnson, J. R. & Stell, A. L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181, 261-272 (2000).
93. Welch, R. A. et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl Acad. Sci. USA 99, 17020-17024 (2002).
94. Bahrani-Mougeot, F. K. et al. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol. Microbiol. 45, 1079-1093 (2002).
95. Gunther, N. W., Lockatell, V., Johnson, D. E. & Mobley, H. L. In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect. Immun. 69, 2838-2846 (2001).
96. Connell, I. et al. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl Acad. Sci. USA 93, 9827-9832 (1996).
97. Mulvey, M. A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic, Escherichia coli. Science 282, 1494-1497 (1998).
98. Anderson, G. G. et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301, 105-107 (2003).
99. Svanborg-Eden, C. & Hansson, H. A. Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells. Infec. Immun. 21, 229-237 (1978).
100. Korhonen, T. K., Virkola, R. & Holthofer, H. Localization of binding sites for purified Escherichia coli P fimbriae in the human kidney. Infect. Immun. 54, 328-332 (1986).
101. Trifillis, A. L. et al. Binding to and killing of human renal epithelial cells by hemolytic P-fimbriated E. coli. Kidney Int. 46, 1083-1091 (1994).
102. 2+ oscillations in renal elpithelial cells. Nature 405, 694-697 (2000).
103. Guyer, D. M., Henderson, I. R., Nataro, J. P. & Mobley, H. L. Identification of Sat, an autotransporter toxin produced by uropathogenic Escherichia coli. Mol. Microbiol. 38, 53-66 (2000).
104. Unhanand, M., Mustafa, M. M., McCracken, G. H. Jr & Nelson, J. D. Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J. Pediatr. 122, 15-21 (1993).
105. Dawson, K. G., Emerson, J. C. & Burns, J. L. Fifteen years of experience with bacterial meningitis. Pediatr. Infect. Dis. J. 18, 816-822 (1999).
106. Stoll, B. J. et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med. 347, 240-247 (2002).
107. Dietzman, D. E., Fischer, G. W. & Schoenknecht, F. D. Neonatal Escherichia coli septicemia-bacterial counts in blood. J. Pediatr. 85, 128-130 (1974).
108. Stins, M. F., Badger, J. L. & Kim, K. S. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb. Pathog. 30, 19-28 (2001).
109. Stins, M. F., Nemani, P. V., Wass, C. & Kim, K. S. Escherichia coli binding to and invasion of brain microvascular endothelial cells derived from humans and rats of different ages. Infect. Immun. 67, 5522-5525 (1999).
110. Kim, K. S. et al. The K1 catowle is the critical determinant in the development of Escherichia coli meningitis in the rat. J. Clin. Invest. 90, 897-905 (1992).
111. Rode, C. K., Melkerson-Watson, L. J., Johnson, A. T. & Bloch, C. A. Type-specific contributions to chromosome size differences in Escherichia coli. Infect. Immun. 67, 230-236 (1999).
112. Bonacorsi, S. P. et al. Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains. Infect. Immun. 68, 2096-2101 (2000).
113. Badger, J. L., Wass, C. A., Weissman, S. J. & Kim, K. S. Application of signature-tagged mutagenesis for identification of Escherichia coli K1 genes that contribute to invasion of human brain microvascular endothelial cells. Infect. Immun. 68, 5056-5061 (2000).
114. Parkkinen, J., Korhonen, T. K., Pere, A., Hacker, J. & Soinila, S. Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J. Clin. Invest 81 860-865 (1988).
115. Prasadarao, N. V., Wass, C. A. & Kim, K. S. Endothelial cell GlcNAc β,1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrier. Infect. Immun. 64, 154-160 (1996).
116. Kim, K. S. Escherichia coli translocation at the blood-brain barrier. Infect. Immun. 69, 5217-5222 (2001).
117. Badger, J. L. & Kim, K. S. Environmental growth conditions influence the ability of Escherichia coli K1 to invade brain microvascular endothelial cells and confer serum resistance. Infect. Immun. 66, 5692-5697 (1998).
118. Hoffman, J. A., Wass, C., Stins, M. F. & Kim, K. S. The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier. Infect. Immun. 67, 3566-3570 (1999).
119. Reddy, M. A., Wass, C. A., Kim, K. S., Schlaepfer, D. D. & Prasadarao, N. V. Involvement of focal adhesion kinase in Escherichia coli invasion of human brain microvascular endothelial cells. Infect. Immun. 68, 6423-6430 (2000).
120. Khan, M. A. & Isaacson, R. E. Identification of Escherichia coli genes that are specifically expressed in a murine model of septicemic infection. Infect. Immun. 70, 3404-3412 (2002).
121. Durfeuille-Michaud, A. Adherent-invasive Escherichia coli a putative new E. coli pathotype associated with Crohn's disease. Int. J. Med. Microbiol. 292, 185-193 (2002).
122. Panigrahi, P., Bamford, P., Horvath, K., Morris, J. G. Jr & Gewolb, I. H. Escherichia coli transcytosis in a Caco-2 cell model: implications in neonatal necrotizing enterocolitis. Pediatr. Res. 40, 415-421 (1996).
123. De Rycke, J., Milon, A. & Oswald, E. Necrotoxic Escherichia coli (NTEC): two emerging categories of human and animal pathogens. Vet. Res. 30, 221-233 (1999).
124. Elliott, S. J. et al. Characterization of the roles of hemolysin and other toxins in enteropathy caused by α-hemolytic Escherichia coli linked to human diarrhea. Infect. Immun. 66 2040-2051 (1998).
125. Toth, I., Herault, F., Beutin, L. & Oswald, E. Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (type IV). J. Clin. Microbiol. 41, 4285-4291 (2003).
126. Janka, A. et al. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7: characterization and evolutionary considerations. Infect. Immun. 71, 3634-3638 (2003).
127. Otto, B. R., van Dooren, S. J., Dozois, C. M., Luirink, J. & Oudega, B. Escherichia coli hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis. Infect. Immun. 70, 5-10 (2002).
128. McVeigh, A. et al. IS1414, an Escherichia coli insertion sequence with a heat-stable enterotoxin gene embedded in a transposase-like gene. Infect. Immun. 68, 5710-5715 (2000).
129. Hacker, J. & Kaper, J. B. Pathogenicity islands and the evolution of microbes. Annu. Rev. Microbiol. 54, 641-679 (2000).
130. Dobrindt, U. et al. Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of uropathogenic Escherichia coli strain 536. Infect. Immun. 70, 6365-6372 (2002).
131. Tauschek, M., Strugnell, R. A. & Robins-Browne, R. M. Characterization and evidence of mobilization of the LEE pathogenicity island of rabbit-specific strains of enteropathogenic Escherichia coli. Mol. Microbiol. 44, 1533-1550 (2002).
132. Torres, A. G. & Kaper, J. B. Pathogenicity islands of intestinal E. coli. Curr. Top. Microbiol. Immunol. 264, 31-48 (2002).
133. Ingersoll, M., Groisman, E. A. & Zychlinsky, A. Pathogenicity islands of Shigella. Curr. Top. Microbiol. Immunol. 264, 49-65 (2002).
134. Redford, P. & Welch, R. A. Extraintestinal Escherichia coli as a model system for the study of pathogenicity islands. Curr. Top. Microbiol. Immunol. 264, 15-30 (2002).
135. Schubert, S., Cuenca, S., Fischer, D. & Heesemann, J. High-pathogenicity island of Yersinia pestis in enterobacteriaceae isolated from blood cultures and urine samples: prevalence and functional expression. J. Infect. Dis. 182, 1268-1271 (2000).
136. Maurelli, A. T., Fernández, R. E., Bloch, C. A., Rode, C. K. & Fasano, A. 'Black holes' and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc. Natl Acad. Sci. USA 95 3943-3948 (1998).
137. Casalino, M., Latella, M. C., Prosseda, G. & Colonna, B. CadC is the preferential target of a convergent evolution driving enteroinvasive Escherichia coli toward a lysine decarboxylase-defective phenotype. Infect. Immun. 71, 5472-5479 (2003).
138. Weissman, S. J., Moseley, S. L., Dykhuizen, D. E. & Sokurenko, E. V. Enterobacterial adhesins and the case for studying SNPs in bacteria. Trends Microbiol. 11, 115-117 (2003).
139. Dobrindt, U. et al. Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays. J. Bacteriol. 185, 1831-1840 (2003).
140. Mellies, J. L., Elliott, S. J., Sperandio, V., Donnenberg, M. S. & Kaper, J. B. The Per regulon of enteropathogenic Escherichia coli identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE -encoded regulator (Ler). Mol. Microbiol. 33, 296-306 (1999 ).
141. Xia, Y., Gally, D., Forsman-Semb, K. & Uhlin, B. E. Regulatory cross-talk between adhesin operons in Escherichia coli: inhibition of type 1 fimbriae expression by the PapB protein. EMBO J. 19, 1450-1457 (2000).
142. Wagner, P. L. et al. Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol. Microbiol. 44, 957-970 (2002).
143. Zhang, X. et al. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181, 664-670 (2000).
144. Sperandio, V., Mellies, J. F., Nguyen, W., Shin, S. & Kaper, J. B. Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli. Proc. Natl Acad. Sci. USA 96 (1999).
145. Sperandio, V., Torres, A. G., Jarvis, B., Nataro, J. P., & Kaper, J. B. Bacteria-host communication: the language of hormones. Proc. Natl Acad. Sci. USA 100, 8951-8956 (2003).
146. Abraham, J. M., Freitag, C. S., Clements, J. R. & Eisenstein B. I. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc. Natl Acad. Sci. USA 82, 5724-5727 (1985).
147. Kuehn, M. J., Heuser, J., Normark, S. & Hultgren, S. J. P pili in uropathogenic E. coli are composite fibres with distinct fibrillar adhesive tips. Nature 356, 252-255 (1992).
148. Bustamante, V. H., Santana, F. J., Calva, E. & Puente, J. L. Transcriptional regulation of type III secretion genes in enteropathogenic Escherichia coli: Ler antagonizes H-NS-dependent repression. Mol. Microbiol. 39, 664-678 (2001).
149. Friedberg, D., Umanski, T., Fang, Y. & Rosenshine, I. Hierarchy in the expression of the locus of enterocyte effacement genes of enteropathogenic Escherichia coli. Mol. Microbiol. 34, 941-952 (1999).
150. Goldberg, M. D., Johnson, M., Hinton, J. C. & Williams, P. H. Role of the nucleoid-associated protein Fis in the regulation of virulence properties of enteropathogenic Escherichia coli. Mol. Microbiol. 41, 549-559 (2001).
151. Grant, A. J. et al. Co-ordination of pathogenicity island expression by the BipA GTPase in enteropathogenic Escherichia coli (EPEC). Mol. Microbiol. 48, 507-521 (2003).
152. Sperandio, V., Li, C. C. & Kaper, J. B. Quorum-sensing Escherichia coli regulator A: a regulator of the LysR family involved in the regulation of the locus of enterocyte effacement pathogenicity island in enterohemorrhagic E. coli. Infect. Immun. 70, 3085-3093 (2002).
153. Sperandio, V., Torres, A. G. & Kaper, J. B. Quorum sensing Escherichia coli regulators B and C (QseBC) a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. Mol. Microbiol. 43, 809-821 (2002).
154. Gómez-Duarte, O. G. & Kaper, J. B. A plasmid-encoded regulatory region activates chromosomal eaeA expression in enteropathogenic Escherichia coli. Infect. Immun. 63, 1767-1776 (1995).
155. Tobe, T., Schoolnik, G. K., Sohel, I., Bustamante, V. H. & Puente, J. L. Cloning and characterization of bfpTVW, genes required for the transcriptional activation of bfpA in enteropathogenic Escherichia coli. Mol. Microbiol. 21, 963-975 (1996).
156. Shin, S. et al. An activator of glutamate decarboxylase genes regulates the expression of enteropathogenic Escherichia coli virulence genes through control of the plasmid-encoded regulator, Per. Mol. Microbiol. 41, 1133-1150 (2001).
157. Mellies, J. L. et al. espC pathogenicity island of enteropathogenic Escherichia coli encodes an enterotoxin. Infect. Immun. 69, 315-324 (2001)